Management of systemic sclerosis

被引：0

作者：

Lim, IGS ^{[1
]}

Schrieber, L ^{[1
]}

机构：

[1] Univ Sydney, Inst Bone & Joint Res, Royal N Shore Hosp, Dept Rheumatol, Sydney, NSW 2006, Australia

来源：

ISRAEL MEDICAL ASSOCIATION JOURNAL | 2002年 / 4卷 / 11期

关键词：

autoimmunity; scleroderma; connective tissue disease; systemic sclerosis;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：953 / 957

页数：5

共 45 条

[1] IMPROVED PULMONARY-FUNCTION IN SYSTEMIC-SCLEROSIS AFTER TREATMENT WITH CYCLOPHOSPHAMIDE [J].

AKESSON, A ;

SCHEJA, A ;

LUNDIN, A ;

WOLLHEIM, FA .

ARTHRITIS AND RHEUMATISM, 1994, 37 (05) :729-735

[2] Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial [J].

Badesch, DB ;

Tapson, VF ;

McGoon, MD ;

Brundage, BH ;

Rubin, LJ ;

Wigley, FM ;

Rich, S ;

Barst, RJ ;

Barrett, PS ;

Kral, KM ;

Jöbsis, MM ;

Loyd, JE ;

Murali, S ;

Frost, A ;

Girgis, R ;

Bourge, RC ;

Ralph, DD ;

Elliott, CG ;

Hill, NS ;

Langleben, D ;

Schilz, RJ ;

McLaughlin, VV ;

Robbins, IM ;

Groves, BM ;

Shapiro, S ;

Medsger, TA ;

Gaine, SP ;

Horn, E ;

Decker, JC ;

Knobil, K .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) :425-+

[3] Phase I/II trial of autologous stem cell transplantation in systemic sclerosis:: procedure related mortality and impact on skin disease [J].

Binks, M ;

Passweg, JR ;

Furst, D ;

McSweeney, P ;

Sullivan, K ;

Besenthal, C ;

Finke, J ;

Peter, HH ;

van Laar, J ;

Breedveld, FC ;

Fibbe, VE ;

Farge, D ;

Gluckman, E ;

Locatelli, F ;

Martini, A ;

van den Hoogen, F ;

van de Putte, L ;

Schattenberg, AVN ;

Arnold, R ;

Bacon, PA ;

Emery, P ;

Espigado, I ;

Hertenstein, B ;

Hiepe, F ;

Kashyap, A ;

Kötter, I ;

Marmont, A ;

Martinez, A ;

Pascual, MJ ;

Gratwohl, A ;

Prentice, HG ;

Black, C ;

Tyndall, A .

ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (06) :577-584

[4]

Black CM, 1999, ARTHRITIS RHEUM, V42, P299, DOI 10.1002/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO

[5]

2-R

[6]

Bolster Marcy B., 1999, Current Opinion in Rheumatology, V11, P508, DOI 10.1097/00002281-199911000-00012

[7] Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study [J].

Channick, RN ;

Simonneau, G ;

Sitbon, O ;

Robbins, IM ;

Frost, A ;

Tapson, VF ;

Badesch, DB ;

Roux, S ;

Rainisio, M ;

Bodin, F ;

Rubin, LJ .

LANCET, 2001, 358 (9288) :1119-1123

[8]

Clements PJ, 1997, J RHEUMATOL, V24, P85

[9]

Clements PJ, 1999, ARTHRITIS RHEUM-US, V42, P1194, DOI 10.1002/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO

[10]

2-7

← 1 2 3 4 5 →